Axogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Axogen and other ETFs, options, and stocks.

About AXGN

Axogen, Inc. engages in the development and marketing of surgical solutions for peripheral nerve regeneration and repair. It provides products and educational resources to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. 

CEO
Michael D. Dale
CEOMichael D. Dale
Employees
622
Employees622
Headquarters
Alachua, Florida
HeadquartersAlachua, Florida
Founded
1977
Founded1977
Employees
622
Employees622

AXGN Key Statistics

Market cap
2.38B
Market cap2.38B
Price-Earnings ratio
-70.56
Price-Earnings ratio-70.56
Dividend yield
Dividend yield
Average volume
1.56M
Average volume1.56M
High today
$45.25
High today$45.25
Low today
$45.25
Low today$45.25
Open price
$44.06
Open price$44.06
Volume
202.00
Volume202.00
52 Week high
$45.98
52 Week high$45.98
52 Week low
$9.52
52 Week low$9.52

Stock Snapshot

As of today, Axogen(AXGN) shares are valued at $45.25. The company's market cap stands at 2.38B, with a P/E ratio of -70.56.

On 2026-06-24, Axogen(AXGN) stock traded between a low of $45.25 and a high of $45.25. Shares are currently priced at $45.25, which is 0.0% above the low and 0.0% below the high.

Axogen(AXGN) shares are trading with a volume of 202, against a daily average of 1.56M.

During the past year, Axogen(AXGN) stock moved between $9.52 at its lowest and $45.98 at its peak.

During the past year, Axogen(AXGN) stock moved between $9.52 at its lowest and $45.98 at its peak.

AXGN News

Investing.com 13h
Axogen shareholders elect board members and approve auditor at annual meeting - Investing.com

...

Axogen shareholders elect board members and approve auditor at annual meeting - Investing.com
TipRanks 15h
AxoGen Shareholders Approve Directors, Auditor and Executive Pay

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

TipRanks 6d
AxoGen’s New Head-to-Head Nerve Repair Study Puts Avance Graft Under the Spotlight

AxoGen (AXGN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more conf...

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own AXGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.